1-1 of 1
Maria Larmar
Close
Sort by
Journal Articles

Clinical Trial Results from the Subgroup of Lymphoma/CLL in a Phase 1 Study of ARQ 092, a Novel Pan AKT-Inhibitor

Wael Harb, Mansoor N. Saleh, MD, Kyriakos P Papadopoulos, MD, Feng Chai, MD, Maria Larmar, Giovanni Abbadessa, MD, Brian Schwartz, MD, Anthony Tolcher, MD
Journal: Blood
Blood (2015) 126 (23): 5116.
https://doi.org/10.1182/blood.V126.23.5116.5116
Published: 2015